about
A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesisA20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomesAnti-viral tetris: modulation of the innate anti-viral immune response by A20.Translational studies of A20 in atherosclerosis and cardiovascular disease.Heterologous protein production using euchromatin-containing expression vectors in mammalian cellsThe differential activity of interferon-α subtypes is consistent among distinct target genes and cell types.Contamination with recombinant IFN accounts for the unexpected stimulatory properties of commonly used IFN-blocking antibodies.Unexpected oncosuppressive role for STAT3 in KRAS-induced lung tumorigenesis.AKT3 drives adenoid cystic carcinoma development in salivary glands.Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processesAfatinib restrains K-RAS–driven lung tumorigenesisBreaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesisNotch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinomaOrthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 ExpressionSTAT3β is a tumor suppressor in acute myeloid leukemiaMTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulationJAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progressionA Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease ConditionsSTAT3: Versatile Functions in Non-Small Cell Lung CancerIDO1+ Paneth cells promote immune escape of colorectal cancerTargeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
P50
Q34467421-D74E6227-4E0E-46D9-B40C-8ACAA3F66F32Q35196919-A393C85C-5495-4C79-9834-B323781E4F71Q35555093-131483F5-84D7-4BD3-8161-FF3187AF8CA9Q38258777-61DE5C1D-27F1-46E2-9A54-A62CB0194A89Q38258780-A0F6F74C-E2B5-4F08-A351-4CB173504861Q38874558-FEEB9963-18F1-4E9E-9083-A968D3A8F566Q42114691-5A1E15D8-74E4-4218-A668-4604E9823884Q42324153-9E3A7517-AE59-441F-B6B2-F42694FB8E17Q42705348-07B729D1-C136-47CC-9CD9-649023367B5DQ47240501-9CC7424D-22FC-448B-9059-5E29B3505525Q59616768-922DCA60-E588-45BE-B737-A176A6F6FBC4Q61714947-DE878914-261A-4AD3-9162-210A5F1205E7Q90327834-2D85C155-07C2-4D5B-9CCB-DE55FED6259AQ91034633-62F0ADA0-0195-4CAE-BC22-DFC789E975D8Q91418808-356898C3-AE91-41FA-9B70-452F98EEE830Q91591549-97A19CDA-7497-4722-B1E2-B61A5819CE8CQ92325656-EBD8DDFA-93CB-414C-9E32-5AF5D1415A48Q92585337-05B2EC67-FAA7-42F6-86BD-EA85EE416311Q92826134-E3336707-2388-417A-82BE-144832770DDCQ94513917-C9C9A303-2CB5-4097-8AD6-4477787DC835Q95660974-C0E63E7F-FEED-4CED-94CC-9706E33A23A2Q96605504-E158D1CD-0A67-44CC-819F-62978D4935C5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Herwig P Moll
@ast
Herwig P Moll
@en
Herwig P Moll
@es
Herwig P Moll
@nl
Herwig P Moll
@sl
type
label
Herwig P Moll
@ast
Herwig P Moll
@en
Herwig P Moll
@es
Herwig P Moll
@nl
Herwig P Moll
@sl
prefLabel
Herwig P Moll
@ast
Herwig P Moll
@en
Herwig P Moll
@es
Herwig P Moll
@nl
Herwig P Moll
@sl
P108
P106
P21
P31
P496
0000-0001-6438-9068
P569
2000-01-01T00:00:00Z